211 related articles for article (PubMed ID: 9007157)
1. Progression of renal disease--can it be reversed? The role of calcium channel blockers and angiotensin-converting enzyme inhibitors.
Boner G
Isr J Med Sci; 1996 Dec; 32(12):1217-21. PubMed ID: 9007157
[TBL] [Abstract][Full Text] [Related]
2. Calcium channels blockers and progression of kidney disease.
Ziakka S; Kaperonis N; Ferentinou E; Karakasis F; Ntatsis G; Kourvelou C; Papagalanis N
Ren Fail; 2007; 29(8):1003-12. PubMed ID: 18067048
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin converting enzyme inhibitors, calcium channel blockers, and their combination in the treatment of glomerular disease.
Ritz E; Orth SR; Strzelczyk P
J Hypertens Suppl; 1997 Mar; 15(2):S21-6. PubMed ID: 9218194
[TBL] [Abstract][Full Text] [Related]
4. [Are all antihypertensive drugs renoprotective?].
Wolf S; Risler T
Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
[TBL] [Abstract][Full Text] [Related]
5. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
Vogt L; Kocks MJ; Laverman GD; Navis G
Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
[TBL] [Abstract][Full Text] [Related]
6. Comparison of renin-angiotensin to calcium channel blockade in renal disease.
Tikkanen I; Johnston CI
Kidney Int Suppl; 1997 Dec; 63():S19-22. PubMed ID: 9407414
[TBL] [Abstract][Full Text] [Related]
7. Calcium channel blockers versus angiotensin-converting enzyme inhibitors: renal effects.
Linas S
Am J Kidney Dis; 1990 Oct; 16(4 Suppl 1):15-9. PubMed ID: 2220796
[TBL] [Abstract][Full Text] [Related]
8. The renoprotective effect of antihypertensive drugs.
Locatelli F; Del Vecchio L; Marai P; Colzani S
J Nephrol; 1998; 11(6):330-6. PubMed ID: 10048500
[TBL] [Abstract][Full Text] [Related]
9. Calcium antagonists and renal protection: emerging perspectives.
Epstein M
J Hypertens Suppl; 1998 Sep; 16(4):S17-25. PubMed ID: 9817188
[TBL] [Abstract][Full Text] [Related]
10. Converting enzyme inhibitors and calcium antagonists in the long-term treatment of hypertension in chronic renal failure.
Lenz T; August P
Wien Klin Wochenschr; 1990 May; 102(11):315-9. PubMed ID: 2195780
[TBL] [Abstract][Full Text] [Related]
11. Prescribing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease.
Ferrari P
Nephrology (Carlton); 2007 Feb; 12(1):81-9. PubMed ID: 17295666
[TBL] [Abstract][Full Text] [Related]
12. Approach to the treatment of diabetic nephropathy.
Burke JM
Pharm Pract Manag Q; 1997 Jul; 17(2):26-35. PubMed ID: 10168175
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive therapy in the presence of proteinuria.
Sarafidis PA; Khosla N; Bakris GL
Am J Kidney Dis; 2007 Jan; 49(1):12-26. PubMed ID: 17185142
[TBL] [Abstract][Full Text] [Related]
14. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
Furumatsu Y; Nagasawa Y; Tomida K; Mikami S; Kaneko T; Okada N; Tsubakihara Y; Imai E; Shoji T
Hypertens Res; 2008 Jan; 31(1):59-67. PubMed ID: 18360019
[TBL] [Abstract][Full Text] [Related]
15. Diabetes and hypertension, the deadly duet: importance, therapeutic strategy, and selection of drug therapy.
Deedwania PC
Cardiol Clin; 2005 May; 23(2):139-52. PubMed ID: 15694743
[TBL] [Abstract][Full Text] [Related]
16. Renin-angiotensin-aldosterone system blockade and renal protection: angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers?
Ruilope LM
Acta Diabetol; 2005 Apr; 42 Suppl 1():S33-41. PubMed ID: 15868118
[TBL] [Abstract][Full Text] [Related]
17. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
18. Calcium channel blockers in the prevention of end stage renal disease: a review.
Derwa A; Peeters P; Vanholder R
Acta Clin Belg; 2004; 59(1):44-56. PubMed ID: 15065696
[TBL] [Abstract][Full Text] [Related]
19. Renal effects of angiotensin-converting enzyme inhibitors that result in cost savings and improved patient outcomes.
Swislocki AL; Siegel D
Am J Manag Care; 2001 Mar; 7(3):283-95. PubMed ID: 11258145
[TBL] [Abstract][Full Text] [Related]
20. Hypertension and progression of renal disease.
Maschio G; Oldrizzi L; Marcantoni C; Rugiu C
J Nephrol; 2000; 13(3):225-7. PubMed ID: 10928300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
